Shukra Pharmaceuticals Clarifies Share Price Movement

Shukra Pharmaceuticals Ltd has responded to an exchange query regarding recent significant price movements in its securities. The company confirmed full compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, stating that all material information has been regularly disclosed. Shukra Pharmaceuticals clarified that there is no undisclosed price-sensitive information or impending corporate event that warrants disclosure at this time. The company attributes the recent share price fluctuation to natural market forces and denies any management involvement in such movements.